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INTRODUCTION
Patellofemoral pain (PFP) typically presents as
diffuse anterior knee pain, usually with activities
such as squatting, running, stair ascent and descent.
It is common in active individuals across the life-
span,1–4 and is a frequent cause for presentation at
physiotherapy, general practice, orthopaedic and
sports medicine clinics in particular.5 6 Its impact is
profound, often reducing the ability of those with
PFP to perform sporting, physical activity and
work-related activities pain-free. Increasing evi-
dence suggests that it is a recalcitrant condition,
persisting for many years.7–9 In an attempt to share
recent innovations, build on the ﬁrst three success-
ful biennial retreats and deﬁne the ‘state of the art’
for this common, impactful condition; the 4th
International Patellofemoral Pain Research Retreat
was convened.
The 4th International Patellofemoral Research
Retreat was held in Manchester, UK, over 3 days
(September 2–4th, 2015). After undergoing peer-
review for scientiﬁc merit and relevance to the
retreat, 67 abstracts were accepted for the retreat
(50 podium presentations, and 17 short presenta-
tions). The podium and short presentations were
grouped into ﬁve categories; (1) PFP, (2) factors
that inﬂuence PFP (3) the trunk and lower extrem-
ity (4) interventions and (5) systematic analyses.
Three keynote speakers were chosen for their scien-
tiﬁc contribution in the area of PFP. Professor
Andrew Amis spoke on the biomechanics of the
patellofemoral joint. Professor David Felson spoke
on patellofemoral arthritis,10 and Dr Michael
Ratleff ’s keynote theme was PFP in the adolescent
patient.11 As part of the retreat, we held structured,
whole-group discussions in order to develop con-
sensus relating to the work presented at the
meeting as well as evidence gathered from the
literature.
Consensus development process
In our past three International Patellofemoral
Research Retreats, we developed a consensus state-
ment addressing different presentation categor-
ies.12–14 In Manchester in 2015, we revised the
format. For the exercise and physical interventions,
we developed consensus based on reviews of sys-
tematic reviews, and these are reported in a com-
panion publication.15 For factors contributing to
PFP, Professor Christopher Powers facilitated the
discussion and development of consensus, which is
published in another companion publication. For
the remaining topics of terminology, deﬁnitions/
diagnosis and features of clinical examination, a
consensus discussion was led by KMC, with the
results described below.
In addition to the consensus activities, two sec-
tions that had been features of prior consensus meet-
ings underwent an update and synthesis of literature.
The evidence related to natural history of PFP and
patellofemoral osteoarthritis (OA) was described by
JJS and KMC, while a recommendation on PROMs
for use in PFP was completed by NJC, DBJ and
JFE, based on the best available evidence.
The following pages present the 4th
Patellofemoral Pain Consensus Statement regarding
terminology, deﬁnitions, clinical examination,
natural history, patellofemoral OA and patient
reported outcomes (PROMs). These statements
represent the contemporary status of knowledge in
the ﬁeld of PFP and hence, will change over time.
This document was developed for clinicians and
researchers, to improve our comprehension of this
problematic condition, and provide a guide for
better and more consistent assessment and manage-
ment. Additionally, gaps in current knowledge can
be identiﬁed and provide a basis for future research
directions.
TERMINOLOGY
Two terms were proposed for the condition: (1)
PFP and (2) patellofemoral arthropathy. PFP has
been used as the preferred term over recent years,
however, it does not take into account how non-
painful joint conditions could be a precursor to
pain development, does not include symptoms such
as crepitus, and may increase a focus on the ‘pain’
aspect of the condition. The alternative term, patel-
lofemoral arthropathy, was proposed, as part of the
increasing recognition that PFP may be a symptom
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of joint disease. Focusing on the disease process (arthropathy)
might not be appropriate because: (A) the linkage between
disease process and pain presentation is not clear, (B) pain is the
predominant symptom, and (C) it could shift the focus to
imaging, rather than clinical outcomes.
Statement 1. The term ‘patellofemoral pain’ is the preferred
term, and is a synonym for other terms including: (1) PFP syn-
drome; (2) chondromalacia patella; (3) anterior knee pain and/
or syndrome; and (4) runner’s knee.
DEFINING PFP
Statement 2. The core criterion required to deﬁne PFP is pain
around or behind the patella, which is aggravated by at least one
activity that loads the patellofemoral joint during weight bearing
on a ﬂexed knee (eg, squatting, stair ambulation, jogging/
running, hopping/jumping).
Additional criteria (not essential):
A. Crepitus or grinding sensation emanating from the patellofe-
moral joint during knee ﬂexion movements
B. Tenderness on patellar facet palpation
C. Small effusion
D. Pain on sitting, rising on sitting, or straightening the knee
following sitting
Statement 3. People with a history of dislocation, or who
report perceptions of subluxation, should not be included in
studies of PFP, unless the study is speciﬁcally evaluating these
subgroups.
Currently, such patients are considered to be a subgroup of
people with patellofemoral disorders and/or pain, who may
have distinct presentations, biomechanical risk factors and
require different treatments approaches.
CLINICAL EXAMINATION OF PFP
Clinical examination is the cornerstone to diagnose PFP,16 17
but there is no deﬁnitive clinical test to diagnose PFP.18
Statement 4. The best available test is anterior knee pain elicited
during a squatting manoeuvre: PFP is evident in 80% of people
who are positive on this test.18
Additional tests (limited evidence):
Tenderness on palpation of the patellar edges (PFP is evident
in 71–75% of people with this ﬁnding.18
Tests with limited diagnostic usefulness
▸ Patellar grinding and apprehension tests (eg, Clarke’s test)
have low sensitivity and limited diagnostic accuracy for
PFP.18 19
▸ Knee range of motion and effusion.
NATURAL HISTORY
Incidence and prevalence of PFP
Statement 5. PFP is common in young adolescents, with a
prevalence of 7–28%,2 20 21 and incidence of 9.2%.20
Few studies have evaluated prevalence or incidence in other
populations, except in the military,4 where the annual incidence
in men is 3.8% and in women is 6.5%, with a prevalence of
12% in men and 15% in women.4
Specialisation in a single sport was associated with a relative
risk (1.5: 95% CI: 1.0 to 2.2) of PFP incidence compared to
multisport athletes.2
PATELLOFEMORAL OSTEOARTHRITIS
Prevalence and impact of patellofemoral OA
Statement 6. Patellofemoral OA is an under recognised yet
important subgroup of knee OA.22 23
Knee OA research has mainly focused on the tibiofemoral
compartment, yet recent evidence suggests that the patellofe-
moral compartment is at least as commonly affected by OA.24–26
Depending on the source population and deﬁnition of OA (ie,
radiographic or MRI) isolated patellofemoral OA is present in
11–24% of older individuals and occurs in combination with
tibiofemoral OA in 4–40% of people. People with patellofe-
moral OA exhibit similar patterns of pain and functional limita-
tion to those with PFP.27–31
Risk factors/factors associated with patellofemoral OA
Statement 7. A variety of factors may alter the mechanics of the
patellofemoral joint and increase joint stress, potentially leading
to OA.
A. Abnormal patellofemoral joint alignment and trochlear
morphology are associated with patellofemoral OA (both
radiographic and MRI features). A recent systematic
review32 concluded that there is strong evidence that patel-
lofemoral OA is associated with both abnormal trochlear
morphology and frontal plane knee alignment. There is also
limited evidence (due to the lack of longitudinal studies)
that malalignment in the sagittal (patella alta) and axial
(lateral patellar displacement and tilt) planes are associated
with patellofemoral OA. However, there remains a knowl-
edge gap regarding optimal measures and thresholds to best
predict patellofemoral OA.
B. Muscle weakness: Quadriceps weakness is an important
factor in patellofemoral OA. Quadriceps function, such as
muscle size,33 strength34 35 and muscle force,36 is impaired
in people with patellofemoral OA. Importantly, quadriceps
weakness is a risk factor for patellofemoral OA.37 Weakness
of muscle groups above the knee (involving the gluteii, often
referred to as the ‘proximal muscles’) is well documented in
young individuals with non-arthritic PFP.16 38–42 Emerging
evidence suggests that those with patellofemoral OA may
also demonstrate proximal muscle dysfunction compared to
controls, including lower gluteus minimus and medius peak
muscle force,43 and lower hip abductor strength.44 These
studies found no differences in gluteus maximus peak
muscle force43 or hip external rotator strength.44 In the
absence of longitudinal studies, the potential for hip muscle
weakness to increase the risk of patellofemoral OA remains
unknown.
C. Abnormal biomechanics: There is recent evidence that indi-
viduals with patellofemoral OA demonstrate abnormal bio-
mechanics during gait.36 43 45–47 Fok et al36 reported that
those with patellofemoral OA had lower knee extension
moments, quadriceps forces and patellofemoral joint reac-
tion forces during stair ascent and descent. In contrast to
these ﬁndings, Pohl et al44 reported that pelvis, hip and
knee kinematics were not different between people with
patellofemoral OA and controls. In the only longitudinal
study to date, Teng et al48 found that peak knee ﬂexion
moment and ﬂexion moment impulse at baseline lead to
progression of patellofemoral cartilage damage over 2 years.
Statement 8. Anterior cruciate ligament reconstruction (ACLR)
increases the risk of patellofemoral OA.
There is radiographic and MRI evidence of patellofemoral
OA following ACLR,49–57 which appears to be independent of
hamstring tendon or bone-patellar-bone autograft. While
further longitudinal studies are required to elucidate the
mechanisms underpinning patellofemoral OA following ACLR,
it may be related to altered biomechanics and concomitant
chondral damage.56 58 Notably, patellofemoral OA following
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ACLR is associated with worse symptoms and function57 and
deteriorating symptoms.59
Relationship between structure and pain
Statement 9. The relationship between abnormal joint structure
and pain is imprecise. Patellofemoral pathology is traditionally
considered to occur in the lateral compartment, which appears
inconsistent with cartilage damage and bone marrow lesions
(BMLs) on MRI (two hallmark features of OA on MRI) present-
ing in the medial and lateral patellofemoral joint.60 61 An inter-
esting ﬁnding was that PFP was only present with lateral
patellofemoral joint damage and with concomitant medial and
lateral structural damage, but not when there was only medial
joint damage.61 In a series of studies, Sharma et al62 found that
PFJ cartilage damage and BMLs were associated with prevalent
frequent knee symptoms and incident persistent symptoms over
5 years and that worsening of preradiographic patelofemoral
damage was associated with persistent knee symptoms.63
Statement 10. The infrapatellar fat pad is an intracapsular and
extrasynovial tissue that is highly innervated and a potential
cause of PFP.
The role of the fat pad in the patellofemoral OA disease
process remains unclear. In a cohort of people with patellofe-
moral OA there was greater fat pad volume compared to con-
trols, and greater fat pad volume was associated with greater
knee pain severity.64 In other cohorts of people with and
without OA, greater fat pad size was associated with greater
medial and lateral tibial and patellar cartilage volume,65 and
predicted lower knee pain at follow-up.66
Treatment of patellofemoral OA
Statement 11. Clinical features of patellofemoral OA may differ
from tibiofemoral OA.
It is possible that in order to target effective rehabilitation
treatments for those with patellofemoral OA, we need to recog-
nise the clinical ﬁndings that identify and discriminate them
from tibiofemoral OA. Schiphof et al67 reported that the pres-
ence of crepitus in the knee and history of patellar pain were
signiﬁcantly associated with patellofemoral joint OA (but not
tibiofemoral joint OA) in women. Other studies reported poor
diagnostic ability of a variety of clinical examination ﬁndings
self-reported knee pain location and with activities to discrimin-
ate those with patellofemoral OA from those with tibiofemoral
OA.34 68 This is an area requiring further investigation, as high-
lighted in the Felson editorial.10
Statement 12. A combined intervention69 (ie, exercise therapy,
education, manual therapy and taping) or patellofemoral bracing70
may improve outcomes for people with patellofemoral OA.
Patellofemoral bracing may improve patellofemoral kinematics
and knee pain and shrink BMLs in those with patellofemoral
OA.70 71 72 The only other study on patellofemoral bracing
found a small but non-signiﬁcant effect on knee pain.73
PATIENT-REPORTED OUTCOME MEASURES
PROMs are used by researchers and clinicians to follow the
course of PFP and evaluate treatment outcomes. Typically admi-
nistered as questionnaires, PROMs measure the patient’s own
perspective of their PFP and treatment, without interpretation
of their response by another individual. This minimises observer
bias, and captures aspects of PFP that are likely to be important
to the patient.
Statement 13. Researchers should use a standard set of PROMs
for PFP and OA to facilitate future comparisons and pooling of
data.
These should encompass three core clinical constructs: pain,
function and global assessment.74 Researchers may also choose
to evaluate quality of life and physical activity (optional con-
structs). Speciﬁc PROMs for each construct will be recom-
mended in an upcoming paper, based on a Delphi exercise.
It should be noted that few PROMs have been developed spe-
ciﬁcally for PFP, raising the possibility that PROMs commonly
used in research to date may lack content validity for this
patient population.
FUTURE DIRECTIONS
The reporting in studies of patients with PFP can limit their
knowledge translation and as a result, a Delphi exercise is
underway, to determine the minimum design and reporting stan-
dards for PFP. The 5th International Patellofemoral Pain
Research Retreat, will be held in Brisbane, Australia in July,
2017.
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